Birrenbach, T.
Wespi, R.
Hautz, W. E.
Berger, J.
Schwab, P. R.
Papagiannakis, G.
Exadaktylos, A. K.
Sauter, T. C.
Article History
Received: 12 February 2023
Accepted: 25 September 2023
First Online: 6 October 2023
Declarations
:
: This study was approved and classified as a quality evaluation study by the local institutional review board (Ethics Committee Bern, BASEC-No: Req-2020-00970). All methods were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all participants.
: Written informed consent was obtained from the participants for the publication of this study and accompanying images. Written informed consent from patients is “not applicable”. No individual details are revealed in the publication.
: WEH has received research funding from the European Union, the Swiss National Science foundation, Zoll foundation, Dräger Medical Germany, Mundipharma Research UK, MDI International Australia, Roche Diagnostics Germany, all outside the submitted work. WEH has provided paid consultancies to AO foundation Switzerland and MDI International Australia, all outside the submitted work. WEH has received financial support for a congress he chaired from EBSCO Germany, Isabel Healthcare UK, Mundipharma Medical Switzerland, VisualDx USA, all outside the submitted work.TCS holds the endowed professorship of emergency telemedicine at the University of Bern sponsored by the Touring Club Switzerland. The sponsor has no influence on the research or decision to publish.GP is co-founder, CEO and CTO of ORamaVR. The company had no influence on the study setup and interpretation of the results or decision to publish.All other authors have nothing to disclose.